Piracetam
- piracetam
- 7491-74-9
- 2-(2-oxopyrrolidin-1-yl)acetamide
- Nootropil
- 2-Oxo-1-pyrrolidineacetamide
- Create:2005-03-25
- Modify:2025-01-18
- 2-Pyrrolidone-N-Acetamide
- Avigilen
- Axonyl
- Cerebroforte
- Cerepar N
- Ciclofalina
- Cuxabrain
- Dinagen
- Gabacet
- Geram
- Memo Puren
- Memo-Puren
- Nootrop
- Nootropil
- Nootropyl
- Normabraïn
- Piracebral
- Piracetam
- Piracetam AbZ
- Piracetam RPh
- Piracetam-RPh
- Piracetrop
- Pirazetam
- Pyracetam
- Pyramem
- Sinapsan
- UCB 6215
- UCB-6215
- UCB6215
- piracetam
- 7491-74-9
- 2-(2-oxopyrrolidin-1-yl)acetamide
- Nootropil
- 2-Oxo-1-pyrrolidineacetamide
- 1-Pyrrolidineacetamide, 2-oxo-
- Nootropyl
- Pyracetam
- Normabrain
- Gabacet
- Pyramem
- Ciclofalina
- Euvifor
- Genogris
- Nootron
- Pirazetam
- Pirroxil
- 2-Pyrrolidinoneacetamide
- Myocalm
- 2-Pyrrolidoneacetamide
- 2-Oxo-pyrrolidine acetamide
- Piracetamum
- Breinox
- Naofukang
- Cl-871
- 1-Acetamido-2-pyrrolidinone
- 2-(2-oxo-pyrrolidin-1-yl)acetamide
- 2-Oxo-pyrrolidin-1-ylacetamide
- 2-Ketopyrrolidine-1-ylacetamide
- UCB 6215
- KT-801
- UCB-6215
- EINECS 231-312-7
- UNII-ZH516LNZ10
- NSC-758191
- BRN 1526393
- ZH516LNZ10
- MLS000069719
- HSDB 7529
- MFCD00079246
- SMR000058196
- 2-(2-Oxopyrrolidino)acetamide
- DTXSID5044491
- 5-21-06-00360 (Beilstein Handbook Reference)
- 2-(2-Oxo-1-pyrrolidinyl)acetamide
- NSC 758191
- NCGC00015821-02
- CAS-7491-74-9
- PIRACETAM (MART.)
- PIRACETAM [MART.]
- Naofukang [Chinese]
- DTXCID3024491
- PIRACETAM (EP MONOGRAPH)
- PIRACETAM [EP MONOGRAPH]
- Cerebroforte
- Avigilen
- Nootrop
- Norzetam
- Axonyl
- Geram
- Piracetamum [INN-Latin]
- 2-Pyrrolidone-N-Acetamide
- SR-01000076071
- Encetrop
- Piracetam [USAN:INN:BAN]
- Piracetam,(S)
- Prestwick_870
- Myocalm (TN)
- Piracetam (Standard)
- Piracetam, EP6.0
- Spectrum_001421
- PIRACETAM [INN]
- PIRACETAM [JAN]
- PIRACETAM [MI]
- PIRACETAM [HSDB]
- PIRACETAM [USAN]
- Opera_ID_1766
- Prestwick0_000537
- Prestwick1_000537
- Prestwick2_000537
- Prestwick3_000537
- Spectrum2_001074
- Spectrum3_001523
- Spectrum4_000742
- Spectrum5_001037
- Lopac-P-5295
- cid_4843
- PIRACETAM [WHO-DD]
- Lopac0_000949
- Oprea1_512927
- SCHEMBL20172
- BSPBio_000553
- BSPBio_002906
- KBioGR_001064
- KBioSS_001901
- Piracetam (JAN/USAN/INN)
- 2-Oxo-1-pyrrolidinylacetamide
- CHEMBL36715
- DivK1c_000259
- SPECTRUM1502195
- SPBio_001088
- SPBio_002474
- 2-(2-ketopyrrolidino)acetamide
- BPBio1_000609
- GTPL4288
- BDBM62877
- CHEBI:32010
- Cl-781
- HMS500M21
- HY-B0585R
- KBio1_000259
- KBio2_001901
- KBio2_004469
- KBio2_007037
- KBio3_002406
- N06BX03
- NINDS_000259
- HMS1569L15
- HMS1921L12
- HMS2092D18
- HMS2096L15
- HMS2230B24
- HMS3262N20
- HMS3371G01
- HMS3657A05
- HMS3713L15
- HMS3885I07
- Pharmakon1600-01502195
- BCP28414
- HY-B0585
- Tox21_110229
- Tox21_301990
- Tox21_500949
- BBL028161
- CCG-39282
- HB0507
- NSC758191
- s3070
- STK535612
- AKOS001038683
- Tox21_110229_1
- 2-(2-Oxo-1-pyrrolidinyl)acetamide #
- DB09210
- LP00949
- SDCCGSBI-0050923.P004
- IDI1_000259
- NCGC00015821-01
- NCGC00015821-03
- NCGC00015821-04
- NCGC00015821-05
- NCGC00015821-06
- NCGC00015821-07
- NCGC00015821-08
- NCGC00015821-10
- NCGC00015821-21
- NCGC00094253-01
- NCGC00094253-02
- NCGC00094253-03
- NCGC00094253-04
- NCGC00255727-01
- NCGC00261634-01
- AC-33158
- AS-13920
- BP166248
- SY066794
- SBI-0050923.P003
- DB-019407
- AB00052287
- EU-0100949
- NS00000504
- P2880
- SW196995-3
- 2-(2-oxidanylidenepyrrolidin-1-yl)ethanamide
- EN300-17044
- Piracetam, VETRANAL(TM), analytical standard
- D01914
- P 5295
- AB00052287_12
- AE-641/30117005
- Q410069
- SR-01000076071-1
- SR-01000076071-4
- SR-01000076071-6
- W-104408
- BRD-K19456237-001-22-7
- BRD-K19456237-001-26-8
- BRD-K19456237-001-27-6
- Z56865289
- Piracetam, European Pharmacopoeia (EP) Reference Standard
120.35 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
129.73 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
134.42 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
98.0601 100
70.0651 56.06
69.0335 25.96
68.0495 4.32
126.0549 1.16
98.0601 100
70.0651 28.58
69.0335 9.77
126.055 3.35
68.0495 1.77
60.9906 999
98.0602 380
70.0683 274
69.0361 159
102.013 88
60.9914 999
69.0365 138
70.0673 111
43.991 64
Use (kg; approx.) in Germany (2009): >50000
Consumption (g per capita; approx.) in Germany (2009): 0.611
Excretion rate: 0.95
Calculated removal (%): 92.1
Not Classified
Reported as not meeting GHS hazard criteria by 58 of 63 companies (only 7.9% companies provided GHS information). For more detailed information, please visit ECHA C&L website.
Aggregated GHS information provided per 63 reports by companies from 6 notifications to the ECHA C&L Inventory.
Reported as not meeting GHS hazard criteria per 58 of 63 reports by companies. For more detailed information, please visit ECHA C&L website.
There are 5 notifications provided by 5 of 63 reports by companies with hazard statement code(s).
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
IMAP assessments - 1-Pyrrolidineacetamide, 2-oxo-: Environment tier I assessment
IMAP assessments - 1-Pyrrolidineacetamide, 2-oxo-: Human health tier I assessment
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=GMZVRMREEHBGGF-UHFFFAOYSA-N
- Australian Industrial Chemicals Introduction Scheme (AICIS)1-Pyrrolidineacetamide, 2-oxo-https://services.industrialchemicals.gov.au/search-assessments/
- CAS Common ChemistryLICENSEThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc/4.0/
- ChemIDplusPiracetam [USAN:INN:BAN]https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0007491749ChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- DrugBankLICENSECreative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)https://www.drugbank.ca/legal/terms_of_use
- DTP/NCILICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuse
- EPA DSSTox2-Oxo-1-Pyrrolidineacetamidehttps://comptox.epa.gov/dashboard/DTXSID5044491CompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-noticePiracetam (EC: 231-312-7)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/60049
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- Hazardous Substances Data Bank (HSDB)
- CCSbaseCCSbase Classificationhttps://ccsbase.net/
- ChEBI
- Open TargetsLICENSEDatasets generated by the Open Targets Platform are freely available for download.https://platform-docs.opentargets.org/licence
- ChEMBLLICENSEAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).http://www.ebi.ac.uk/Information/termsofuse.htmlChEMBL Protein Target Treehttps://www.ebi.ac.uk/chembl/g/#browse/targets
- ClinicalTrials.govLICENSEThe ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use
- Comparative Toxicogenomics Database (CTD)LICENSEIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.http://ctdbase.org/about/legal.jsp
- IUPHAR/BPS Guide to PHARMACOLOGYLICENSEThe Guide to PHARMACOLOGY database is licensed under the Open Data Commons Open Database License (ODbL) https://opendatacommons.org/licenses/odbl/. Its contents are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-sa/4.0/)https://www.guidetopharmacology.org/about.jsp#licenseGuide to Pharmacology Target Classificationhttps://www.guidetopharmacology.org/targets.jsp
- Therapeutic Target Database (TTD)
- Crystallography Open Database (COD)LICENSEAll data in the COD and the database itself are dedicated to the public domain and licensed under the CC0 License. Users of the data should acknowledge the original authors of the structural data.https://creativecommons.org/publicdomain/zero/1.0/
- The Cambridge Structural Database
- EPA Chemical and Products Database (CPDat)EPA CPDat Classificationhttps://www.epa.gov/chemical-research/chemical-and-products-database-cpdat
- NORMAN Suspect List ExchangeLICENSEData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0https://creativecommons.org/licenses/by/4.0/PIRACETAMNORMAN Suspect List Exchange Classificationhttps://www.norman-network.com/nds/SLE/
- EU Clinical Trials Register
- Human Metabolome Database (HMDB)LICENSEHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.http://www.hmdb.ca/citingHMDB0256585_msms_2228591https://hmdb.ca/metabolites/HMDB0256585#spectra
- NIST Mass Spectrometry Data CenterLICENSEData covered by the Standard Reference Data Act of 1968 as amended.https://www.nist.gov/srd/public-lawPiracetamhttp://www.nist.gov/srd/nist1a.cfm
- Japan Chemical Substance Dictionary (Nikkaji)
- KEGGLICENSEAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial licensehttps://www.kegg.jp/kegg/legal.htmlTherapeutic category of drugs in Japanhttp://www.genome.jp/kegg-bin/get_htext?br08301.kegAnatomical Therapeutic Chemical (ATC) classificationhttp://www.genome.jp/kegg-bin/get_htext?br08303.kegTarget-based classification of drugshttp://www.genome.jp/kegg-bin/get_htext?br08310.keg
- MassBank Europe
- MassBank of North America (MoNA)LICENSEThe content of the MoNA database is licensed under CC BY 4.0.https://mona.fiehnlab.ucdavis.edu/documentation/license
- Metabolomics Workbench
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseNCI Thesaurushttps://ncit.nci.nih.gov
- SpectraBase
- WHO Anatomical Therapeutic Chemical (ATC) ClassificationLICENSEUse of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.https://www.whocc.no/copyright_disclaimer/
- Protein Data Bank in Europe (PDBe)
- RCSB Protein Data Bank (RCSB PDB)LICENSEData files contained in the PDB archive (ftp://ftp.wwpdb.org) are free of all copyright restrictions and made fully and freely available for both non-commercial and commercial use. Users of the data should attribute the original authors of that structural data.https://www.rcsb.org/pages/policies
- Springer Nature
- Thieme ChemistryLICENSEThe Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc-nd/4.0/
- Wikidata
- WikipediaLevetiracetamhttps://en.wikipedia.org/wiki/Levetiracetam
- Wiley
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.htmlNootropic Agentshttps://www.ncbi.nlm.nih.gov/mesh/68018697Neuroprotective Agentshttps://www.ncbi.nlm.nih.gov/mesh/68018696
- PubChem
- GHS Classification (UNECE)GHS Classification Treehttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
- EPA Substance Registry ServicesEPA SRS List Classificationhttps://sor.epa.gov/sor_internet/registry/substreg/LandingPage.do
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 403410126https://pubchem.ncbi.nlm.nih.gov/substance/403410126
- NCBI